AKUMS FOCUS

Akums is known for developing new formulations, undertaking bioequivalence studies, and clinical trials, and obtaining the Drug Controller General of India’s (DCGI) approval for manufacturing and marketing of new Fixed Dose Combinations (FDCs) & molecules. Akums also offers new formulations developed with Akums’s technology to its customers under their brand names. Akums also manufactures innovative and technology-driven products.

Business Model

Our business model focuses on end-to-end pharmaceutical solutions, encompassing R&D, manufacturing, quality assurance, and regulatory compliance. We collaborate with global partners, ensuring innovation, efficiency, and scalability across diverse therapeutic segments.

Contract Research & Manufacturing Services (CRAMS)

Contract Research & Manufacturing Services (CRAMS)

Technology Transfer

Technology Transfer

Loan License

Loan License

Contract Development

Contract Development

Novel Drug Delivery systems (N.D.D.S)

Novel Drug Delivery systems (N.D.D.S)

Novel / 1st time launches in India with DCGI Approvals

Novel / 1st time launches in India with DCGI Approvals

Technical Collaboration & Joint Venture

Technical Collaboration & Joint Venture

×

BUILD OR ENHANCE YOUR CURRENT SUPPLY WITH AKUMS

Partner with Akums to elevate your pharmaceutical, nutraceutical, and cosmetic supply chain. As India's leading CDMO, we offer end-to-end solutions, including R&D, formulation development, and large-scale manufacturing. Our state-of-the-art facilities comply with stringent global standards, ensuring product safety, efficacy, and quality. With a strong focus on innovation, we deliver tailored solutions to meet your unique business needs. Whether you're launching a new product or enhancing your current supply chain, Akums provides reliable expertise, seamless scalability, and unwavering commitment to excellence. Join hands with Akums to strengthen your brand and achieve sustained growth in competitive markets.




    Manage Your Cookie Preferences